Questcor Pharmaceuticals | Evaluate

August 11, 2015

Mallinckrodt buys cancer cell therapy for $1.3bn

Sovaldi not the first to break the bank

April 10, 2014

Q1 M&A data underline strong sentiment in life science sector

April 08, 2014

Mallinckrodt dashes hopes of a return to valuation fundamentals

April 07, 2014

Big pharma benefits from biotech carnage in Q1

February 13, 2014

Retrophin moves a step closer to becoming the new Questcor

June 12, 2013

Questcor gives the bulls another short-term reason to cheer

January 07, 2013

All change as big pharma rounds off a stellar 2012

January 04, 2013

BioVectra deal shows Questcor’s faith in Acthar

November 30, 2012

Big beasts exert influence as biotech comes back from the dead

October 09, 2012

Big pharma and biotech shines in first nine months of 2012

Load More